Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP618573.RAbaSokd7RqB3r9WRbDUHthG7L2lKLNE2U6MHnRQop_0E130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP618573.RAbaSokd7RqB3r9WRbDUHthG7L2lKLNE2U6MHnRQop_0E130_assertion type Assertion NP618573.RAbaSokd7RqB3r9WRbDUHthG7L2lKLNE2U6MHnRQop_0E130_head.
- NP618573.RAbaSokd7RqB3r9WRbDUHthG7L2lKLNE2U6MHnRQop_0E130_assertion description "[The aim of this study was to develop a population pharmacokinetic model of vincristine in a paediatric population treated for solid tumour disease and evaluate the impact of different ABCB1, CYP3A4 and CYP3A5 polymorphisms on the different pharmacokinetic parameters.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP618573.RAbaSokd7RqB3r9WRbDUHthG7L2lKLNE2U6MHnRQop_0E130_provenance.
- NP618573.RAbaSokd7RqB3r9WRbDUHthG7L2lKLNE2U6MHnRQop_0E130_assertion evidence source_evidence_literature NP618573.RAbaSokd7RqB3r9WRbDUHthG7L2lKLNE2U6MHnRQop_0E130_provenance.
- NP618573.RAbaSokd7RqB3r9WRbDUHthG7L2lKLNE2U6MHnRQop_0E130_assertion SIO_000772 21404110 NP618573.RAbaSokd7RqB3r9WRbDUHthG7L2lKLNE2U6MHnRQop_0E130_provenance.
- NP618573.RAbaSokd7RqB3r9WRbDUHthG7L2lKLNE2U6MHnRQop_0E130_assertion wasDerivedFrom befree-20150227 NP618573.RAbaSokd7RqB3r9WRbDUHthG7L2lKLNE2U6MHnRQop_0E130_provenance.
- NP618573.RAbaSokd7RqB3r9WRbDUHthG7L2lKLNE2U6MHnRQop_0E130_assertion wasGeneratedBy ECO_0000203 NP618573.RAbaSokd7RqB3r9WRbDUHthG7L2lKLNE2U6MHnRQop_0E130_provenance.